ERIC Number: EJ1426465
Record Type: Journal
Publication Date: 2024-Jun
Pages: 8
Abstractor: As Provided
ISBN: N/A
ISSN: ISSN-0162-3257
EISSN: EISSN-1573-3432
Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder
Amber Davis; Kathryn Van Eck; Nikeea Copeland-Linder; Karen Phuong; Harolyn M.E. Belcher
Journal of Autism and Developmental Disorders, v54 n6 p2347-2354 2024
Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mortality for people with ASD were found to be greater than individuals without ASD when adjusted for sociodemographic characteristics. Hospitalization and mortality was associated with a dose-response increase to comorbidity counts (1 to 5+). Odds of mortality remained greater for those with ASD when adjusting for comorbid health conditions. ASD is a risk factor for COVID-19 mortality. Comorbid health conditions play a particular role in increasing the odds of COVID-19 related hospitalization and death for ASD patients.
Descriptors: Hospitals, Autism Spectrum Disorders, Risk, COVID-19, Pandemics, Comorbidity, Patients, Death, Health Insurance, Mortality Rate
Springer. Available from: Springer Nature. One New York Plaza, Suite 4600, New York, NY 10004. Tel: 800-777-4643; Tel: 212-460-1500; Fax: 212-460-1700; e-mail: customerservice@springernature.com; Web site: https://bibliotheek.ehb.be:2123/
Publication Type: Journal Articles; Reports - Research
Education Level: N/A
Audience: N/A
Language: English
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (DHHS/NIH)
Authoring Institution: N/A
Grant or Contract Numbers: T32HD094687